Vanadium Compounds: Biochemical and Therapeutic Applications: Developments in Molecular and Cellular Biochemistry, cartea 16
Editat de Ashok K. Srivastava, Jean-Louis Chiassonen Limba Engleză Hardback – 30 apr 1996
Din seria Developments in Molecular and Cellular Biochemistry
- 5% Preț: 381.37 lei
- 24% Preț: 1056.97 lei
- 18% Preț: 1198.89 lei
- 24% Preț: 1060.04 lei
- Preț: 396.17 lei
- 5% Preț: 363.85 lei
- 18% Preț: 1523.95 lei
- 24% Preț: 1568.12 lei
- 24% Preț: 1580.08 lei
- 24% Preț: 1584.02 lei
- 5% Preț: 358.27 lei
- 24% Preț: 1564.06 lei
- 24% Preț: 1077.72 lei
- 15% Preț: 570.83 lei
- 24% Preț: 1583.80 lei
- 5% Preț: 657.69 lei
- 18% Preț: 1197.82 lei
- 24% Preț: 801.38 lei
- 24% Preț: 1098.57 lei
- 18% Preț: 921.03 lei
- 24% Preț: 1060.10 lei
- 5% Preț: 1003.85 lei
- 18% Preț: 916.70 lei
- 5% Preț: 1389.69 lei
- 24% Preț: 795.19 lei
- 18% Preț: 927.99 lei
- 15% Preț: 630.01 lei
- 24% Preț: 808.09 lei
- 18% Preț: 932.01 lei
Preț: 719.71 lei
Preț vechi: 757.60 lei
-5% Nou
Puncte Express: 1080
Preț estimativ în valută:
137.75€ • 144.52$ • 114.27£
137.75€ • 144.52$ • 114.27£
Carte tipărită la comandă
Livrare economică 29 ianuarie-12 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780792337621
ISBN-10: 079233762X
Pagini: 246
Ilustrații: VI, 246 p. 5 illus.
Dimensiuni: 216 x 280 x 16 mm
Greutate: 0.89 kg
Ediția:1995
Editura: Springer Us
Colecția Springer
Seria Developments in Molecular and Cellular Biochemistry
Locul publicării:New York, NY, United States
ISBN-10: 079233762X
Pagini: 246
Ilustrații: VI, 246 p. 5 illus.
Dimensiuni: 216 x 280 x 16 mm
Greutate: 0.89 kg
Ediția:1995
Editura: Springer Us
Colecția Springer
Seria Developments in Molecular and Cellular Biochemistry
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I: Chemistry.- The chemistry of peroxovanadium compounds relevant to insulin mimesis.- Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents.- Peroxo heteroligand vanadates(V): Synthesis, spectra-structure relationships, and stability toward decomposition.- Chemically and photochemically initiated DNA cleavage by an insulin-mimetic bisperoxovanadium complex.- II: Biochemical and physiological studies.- Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatases.- Peroxovanadium compounds: Biological actions and mechanism of insulin-mimesis.- Unique and selective mitogenic effects of vanadate on SV40-transformed cells.- Vanadium salts stimulate mitogen-activated protein (MAP) kinases and ribosomal S6 kinases.- Protective effect of vanadate on oxyradical-induced changes in isolated perfused heart.- In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals.- The relationship between insulin and vanadium metabolism in insulin target tissues.- Modulation of insulin action by vanadate: Evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling.- Reversal of defective G-proteins and adenylyl cyclase/cAMP signal transduction in diabetic rats by vanadyl sulphate therapy.- Effects of vanadate on the expression of genes involved in fuel homeostasis in animal models of Type I and Type II diabetes.- Decrease in protein tyrosine phosphatase activities in vanadate-treated obese Zucker (fa/fa) rat liver.- Evidence for selective effects of vanadium on adipose cell metabolism involving actions on cAMP-dependent proteinkinase.- The enhancement by pervanadate of tyrosine phosphorylation on prostatic proteins occurs through the inhibition of membrane-associated tyrosine phosphatases.- Contractile effects of vanadate on aorta rings from virgin and pregnant rats.- In vivo modulation of N-myristoyltransferase activity by orthovanadate.- Regulation and control of glucose overutilization in erythrocytes by vanadate.- In vitro and in vivo antineoplastic effects of ortrovanadate.- Membrane — vanadium interaction: A toxicokinetic evaluation.- III: Potential use in therapy and toxicological studies.- Increased potency of vanadium using organic ligands.- In vivo effects of peroxovanadium compounds in BB rats.- Long-term antidiabetic activity of vanadyl after treatment withdrawal: Restoration of insulin secretion?.- Long-term correction of STZ-diabetic rats after short-term i.p. VOSO4 treatment: Persistence of insulin secreting capacities assessed by isolated pancreas studies.- Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats.- Vanadate induces normolipidemia and a reduction in the levels of hepatic iipogenic enzymes in obese Zucker rat.- In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus.- Toxicology of vanadium compounds in diabetic rats: The action of chelating agents on vanadium accumulation.- Index to Volume 153.